Journal of Current Glaucoma Practice

Register      Login

VOLUME 6 , ISSUE 1 ( 2012 ) > List of Articles

REVIEW ARTICLE

Optical Coherence Tomography in Glaucoma

P Sathyan, Shilpa, Anitha

Citation Information : Sathyan P, Anitha S. Optical Coherence Tomography in Glaucoma. J Curr Glaucoma Pract 2012; 6 (1):1-5.

DOI: 10.5005/jp-journals-10008-1099

License: CC BY 4.0

Published Online: 00-04-2012

Copyright Statement:  Copyright © 2012; Jaypee Brothers Medical Publishers (P) Ltd.


Abstract

The optic disk and the RNFL are the principal sites of apparent glaucomatous damage which precedes glaucomatous visual field alterations. RNFL defects are known to precede detection of visual field defects by approximately 6 years. Accurate early detection and monitoring of ONH and RNFL defects has become the prime focus of effective management of glaucoma. Optical coherence tomography employs low-coherence interferometry to obtain cross-sectional images of the ocular tissues. This review attempts to critically analyse the applications of both, anterior and posterior segment OCT in glaucoma management.


PDF Share
  1. Rand AR. Shield's textbook of glaucoma. (6th edn). Lippincott: Williams and Wilkins; 2011;77-78.
  2. Robert LS, Mark FL, Michael VD. Becker-Shaffer's diagnosis and therapy of the glaucomas. (8th edn). Mosby: Elsevier; 2009;175-81.
  3. Sommer A, Katz J, Quigley HA, et al. Clinically detectable nerve layer atrophy precedes the onset of glaucomatous field loss. Arch Ophthalmol 1991;109:77-83.
  4. Tarek MS, Mark BS, Roger AH, Jonathan GC. Glaucoma-medical diagnosis and therapy. Saunders: Elsevier; 2009;1:232-35.
  5. Schuman JS, Hee MR, Fuliafito CA, et al. Quantification of nerve fibre layer thickness in normal and glaucomatous eyes using optical coherence tomography. Arch Ophthalmol 1995;113:586-96.
  6. Leung CK, Cheung CY. Weinreb RN, et al. RNFL imaging with Spectral-domain OCT: A variability and diagnostic performance study. Ophthalmology 2009;116:1257-63.
  7. Leung CK, Chan WM, Yung WH, et al. Comparison of macular and peripapillary measurements for the detection of glaucoma: An OCT study. Ophthalmology 2005;112:391-400.
  8. Parikh RS, Parikh S, Sekhar GC, et al. Diagnostic capability of OCT (Stratus OCT 3) in early glaucoma. Ophthalmology 2007;114:2238-43.
  9. Chang RT, et al. Sensitivity and specificity of Time-domain versus Spectral-domain OCT in diagnosing early to moderate glaucoma. Ophthalmology 2009;116:2294-99.
  10. Bhagwanjee S, Rocke DA, Rout CC, Koovarjee RV, Brijball R. Prevention of hypotension following spinal anaesthesia for elective caesarean section by wrapping of legs. Br J Anaesth 1990 Dec;65(6):819-822.
  11. Goudie TA, Winter AW, Ferguson DJ. Lower limb compression using inflatable splints to prevent hypotension during spinal anaesthesia for caesarean section. Acta Anaesthesiol Scand 1988 Oct;32(7):541-544.
  12. Ralston DH, Shnider SM, DeLorimier AA. Effects of equipotent ephedrine, metaraminol on uterine blood flow in pregnancy. Anesthesiology 1974 Apr;40(4):354-370.
  13. Gutsche BB. Prophylatic ephedrine proceeding spinal analgesia for cesarean section. Anesthesiology 1976;45:462-465.
  14. Weiner, N. Nor epinephrine, epinephrine. In: Goodman LS, Gilman A, Gilman AG, editors. Goodman and Gilman's pharmacological basis for therapeutics. 7th ed. New York: Macmillan; 1985. pp. 145-180.
  15. Barka AS, Taha SK, Ghabach MB, Sibaii AA, Nader AM. Intravascular administration of polymerized gelatin Vs isotonic saline for prevention of spinal induced hypotension. Anesth Analg 1994 Feb;78(2):301-305.
  16. Vercauteren MP, Hoffman V, Coppejans HC, Van Steenberge AL, Adriaensen HA. Hydroxyethylstarch compared with modified gelatin as volume preload before spinal anaesthesia for caesarean section. Br J Anaesth 1990;76:731-733.
  17. Wennberg E, Frid I, Haljamäe H, Wennergren M, Kjellmer I. Comparison of Ringer's acetate with 3% dextran for volume loading. Br J Anesth 1990 Nov;65(5):654-660.
  18. Rout CC, Akoojee SS, Rocke DA, Gouws E. Rapid administration of crystalloid preload does not decrease the incidence of hypotension after spinal anaesthesia for caesarean section. Br J Anaesth 1992 Apr;68(4):394-397.
  19. Wollman SB, Marx GF. Acute hydration for prevention of hypotension of spinal anesthesia in parturient. Anesthesiology 1968 Mar-Apr;29(2):374-380.
  20. Rout CC, Rocke DA, Levin J, Gouws E, Reddy D. A reevaluation of the role of crystalloid preload in the prevention of hypotension associated with spinal anesthesia for elective cesarean section. Anesthesiology 1993 Aug;79(2):262-269.
  21. Riley ET, Cohen SE, Rubenstein AJ, Flanagan B. Prevention of hypotension after spinal anaesthesia for cesarean section: 6% heptastich versus lactated ringer's solution. Anesth Analg 1995 Oct;81(4):838-842.
  22. Karinen J, Räsänen J, Alahuhta S, Jouppila R, Jouppila P. Effect of crystalloid and colloid on uteroplacental and maternal hemodynamics. Br J Anaesth 1995 Nov;75(5):531-535.
  23. Dahlgren G, Granath F, Pregner K, Rösblad PG, Wessel H, Irestedt L. Colloid vs. crystalloid Preloading to prevent maternal hypotension during spinal anaesthesia for elective caesarean section. Acta Anaesthesiol Scand 2005 Sep;49(8):1200-1206.
  24. Teoh WH, Sia AT. Colloid preload versus coload for spinal anaesthesia for caesarean delivery: the effects on maternal cardiac output. Anaesth Analg 2009 May;108(5):1592-1598
  25. Siddik-Sayyid SM, Nasr VG, Taha SK, Zbeide RA, Shehade JM, Al Alami AA, Mokadem FH, Abdallah FW, Baraka AS, Aouad MT. A Randomized trial comparing colloid preload to coload during spinal anaesthesia for elective caesarean delivery. Anaesth Analg 2009 Oct;109(4):1219-1224.
  26. Riaz A, Munzar Z. Preloading before spinal anaesthesia for Caesarean section. A comparison between colloid and crystalloid preload. Anaesth Pain Intens Care 2006;10(1):9-12.
  27. Bridenbaugh, P0.; Kennedy, WF. Spinal, subarachanoid neural blockade. In: Cousins MJ, Bridenbaugh PO, ediors. Neural blockade in clinical anesthesia and management of pain. Philadelphia (PA): Lippincott Williams & Wilkins; 1998. pp. 168-171.
  28. Cheek, TG.; Gutsche, BB. Maternal physiological alterations during pregnancy. In: Shnider SM, Levinson G, editors. Anesthesia for obstetrics. 3rd ed. Baltimore (MD): Williams and Wilkins; 1993. pp. 3-17.
  29. McCrae AF, Wildsmith JA. Preventing and treatment of hypotension during central neural block. Br J Anesth 1993 Jun;70(6):672-680.
  30. Kotsiomiti E, Tzialla A, Hatjivasiliou K. Accuracy and stability of impression materials subjected to chemical disinfection—a literature review. J Oral Rehabil. 2008; 35(4):291-9.
  31. Gountenoudis M. Bestimmung der Randspaltbreite hochgoldhaltiger Restaurationen unter Berücksichtigung der Präparationsform der Abformmethodik und des Abformmaterials [dissertation]. Giessen: Justus-Liebig-Universität; 2003. p. 14-7.
  32. Boeckler AF, Stadler A, Setz JM. The significance of marginal gap and overextension measurement in the evaluation of the fit of complete crowns. J Contemp Dent Pract. 2005; 6(4):26-37.
  33. Donath K, Roth K. Histologischmorphometrische Studie zur Bestimmung des zervikalen Randschlusses von Einzelevaluation und Pfeilerkronen. [Histologic-morphometric studies to determine the cervical marginal fit of singe and pontic crowns.] Z Stomatol. 1987; 84(2):53-73.
  34. Gassino G, Barone Monfrin S, Scanu M, Spina G, Preti G. Marginal adaptation of fixed prosthodontics: a new in vitro 360-degree external examination procedure. Int J Prosthodont. 2004; 17(2):218-23.
  35. Dreyer-Jørgensen K. Prüfungsergebnisse zahnärztlicher Gussverfahren. Dtsch Zahnärztl Z. 1958;13:461–9.
  36. Christensen GJ. Marginal fit of gold inlay castings. J Prosthet Dent. 1966; 16(2): 297-305.
  37. McLean JW, von Fraunhofer JA. The estimation of cement film thickness by an in vivo technique. Br Dent J. 1971; 131(3):107-11.
  38. Kim KM, Lee JS, Kim KN, Shin SW. Dimensional changes of dental impression materials by thermal changes. J Biomed Mater Res. 2001; 58(3):217-20.
  39. Haque MM, Alsareii SA. A review of the therapeutic effects of using miswak (Salvadora persica) on oral health. Saudi Med J 2015 May;36(5):530-543.
  40. Ramachandra JA, Nihal NK, Nagarathna C, Vora MS. Root canal irrigants in primary teeth. World J Dent 2015 Oct-Dec;6(3):229-234.
  41. Sahota MBK, Ahmed K. A review on a life of spice turmeric (curcuma longa). Sci Int (Lahore) 2015;28(1):375-378.
  42. Rai D, Singh JK, Roy N, Panda D. Curcumin inhibits FtsZ assembly: an attractive mechanism for its antibacterial activity. Biochemical J 2008 Feb;410(1):147-155.
  43. Sinha DJ, Vasudeva A, Gowhar O, Garg P, Sinha A, Prakash P. Comparison of antimicrobial efficacy of Propolis, Azadirachta indica (Neem), Melaleuca alternifolia (Tea tree oil), Curcuma longa (Turmeric) and 5% Sodium hypochlorite on Candida albicans biofilm formed on tooth substrate: An in-vitro study. J Pharm Biomed Sci 2015 Jun;5(6):469-474.
  44. Mandroli PS, Bhat K. An in-vitro evaluation of antibacterial activity of curcumin against common endodontic bacteria. J Appl Pharm Sci 2013 Oct;3(10):106-108.
  45. Damre PG. Comparative evaluation of antimicrobial activity of herbal vs chemical root canal irrigants against E. Faecalis—an in vitro study. Int J Adv Res 2015 Sep;3(9):1563-1572.
  46. Kumar H. An in vitro evaluation of the antimicrobial efficacy of Curcuma longa, Tachyspermum ammi, chlorhexidine gluconate, and calcium hydroxide on Enterococcus faecalis. J Conserv Dent 2013 Mar;16(2):144-147.
  47. Andersson M, Carlsson L, Persson M, Bergman B. Accuracy of machine milling and spark erosion with a CAD/CAM system. J Prosthet Dent 1996 Aug;76(2):187-193.
  48. Henkel GL. A comparison of fixed prostheses generated from conventional vs digitally scanned dental impressions. Compend Contin Educ Dent 2007 Aug;28(8):422-424, 426-428, 430-431.
  49. Speaker MG, Arentsen JJ, Laibson PR. Long-term survival of large diameter penetrating keratoplasties for keratoconus and pellucid marginal degeneration. Acta Ophthalmol Suppl 1989;192:17-19.
  50. Jinabhai A, Radhakrishnan H, O'Donnell C. Pellucid corneal marginal degeneration: a review. Contact Lens Anterior Eye 2011 Apr;34(2):56-63.
  51. Kaushal S, Jhanji V, Sharma N, Tandon R, Titiyal JS, Vajpayee RB. “Tuck In” lamellar keratoplasty (TILK) for corneal ectasias involving corneal periphery. Br J Ophthalmol 2008 Feb;92(2):286-290.
  52. Schanzlin DJ, Sarno EM, Robin JB. Crescentic lamellar keratoplasty for pellucid marginal degeneration. Am J Ophthalmol 1983 Aug;96(2):253-254.
  53. Kremer I, Sperber LT, Laibson PR. Pellucid marginal degeneration treated by lamellar and penetrating keratoplasty. Arch Ophthalmol 1993 Feb;111(2):169-170.
  54. Rasheed K, Rabinowitz YS. Surgical treatment of advanced pellucid marginal degeneration. Ophthalmology 2000 Oct;107(10):1836-1840.
  55. Jabbarvand M, Hashemian H, Khodaparast M, Hassanpour N, Mohebbi M. Intrastromal lamellar keratoplasty in patients with pellucid marginal degeneration. J Cataract Refract Surg 2015 Jan;41(1):2-8.
  56. MacLean H, Robinson LP, Wechsler AW. Long-term results of corneal wedge excision for pellucid marginal degeneration. Eye (Lond) 1997;11(Pt 5):613-617.
  57. Javadi MA, Karimian F, Hosseinzadeh A, Noroozizadeh HM, Sa'eedifar MR, Rabie HM. Lamellar crescentic resection for pellucid marginal corneal degeneration. J Refract Surg 2004 Mar-Apr;20(2):162-165.
  58. Fronterre A, Portesani GP. Epikeratoplasty for pellucid marginal corneal degeneration. Cornea 1991 Sep;10(5):450-453.
  59. Ramez Barbara J, Barbara R, Zadok D, et al. Collagen Corneal Cross-Linking followed by Intac Implantation in a Case of Post-PRK Ectasia. Int J Keratoco Ectatic Corneal Dis 2012;1(1):68-72.
  60. Yeung SN, Ku JYF, Lichtinger A, Low SAW, Kim P, Rootman DS. Efficacy of single or paired intrastromal corneal ring segment implantation combined with collagen crosslinking in keratoconus. J Cataract Refract Surg 2013 Aug;39(8):1146-1151.
  61. Kiliç A, Kamburoglu G, Akinci A. Riboflavin injection into the corneal channel for combined collagen crosslinking and intrastromal corneal ring segment implantation. J Cataract Refract Surg 2012 May;38(5):878-883.
  62. Ferenczy PA, Dalcegio M, Koehler M, Pereira TS, Moreira H, Bugmann ML. Femtosecond-assisted intrastromal corneal ring implantation for keratoconus treatment: a comparison with crosslinking combination. Arq Bras Oftalmol 2015 Mar-Apr;78(2):76-81.
  63. Baikoff G, Joly P. Comparison of minus power anterior chamber intraocular lenses and myopic epikeratoplasty in phakic eyes. Refract Corneal Surg 1990 Jul-Aug;6(4):252-260.
  64. Baikoff G. Phakic anterior chamber intraocular lenses. Int Ophthalmol Clin 1991 Winter;31(1):75-86.
  65. Fechner PU, Worst JG. A new concave intraocular lens for the correction of myopia. Eur J Implant Refract Surg 1989 Mar;1(1):41-43.
  66. Brauweiler PH, Wehler T, Busin M. High incidence of cataract formation after implantation of a silicone posterior chamber lens in phakic, highly myopic eyes. Ophthalmology 1999 Sep;106(9):1651-1655.
  67. Zhang X, Tao X-C, Li Z-W, Zhou W-Y, Ma P, Zhang C-X, Wang Y-M, Mu G-Y. Combining corneal crosslinking and phakic toric implantable collamer lenses for the treatment of keratectasia: a case report. Exp Ther Med 2016 Sep;12(3):1495-1498.
  68. Cakir H, Utine CA. Combined kerarings and Artisan/Artiflex IOLs in keratectasia. J Refract Surg 2011 Feb;27(2):119-126.
  69. Moshirfar M, Fenzl CR, Meyer JJ, Neuffer MC, Espandar L, Mifflin MD. Simultaneous and sequential implantation of Intacs and verisyse phakic intraocular lens for refractive improvement in keratectasia. Cornea 2011 Feb;30(2):158-163.
  70. Thompson RW Jr, Price MO, Bowers PJ, Price FW Jr. Long-term graft survival after penetrating keratoplasty. Ophthalmology 2003 Jul;110(7):1396-1402.
  71. McAllum PJ, Segev F, Herzig S, Rootman DS. Deep anterior lamellar keratoplasty for post-LASIK ectasia. Cornea 2007 May;26(4):507-511.
  72. Villarrubia A, Perez-Santonja JJ, Palacin E, Rodriguez-Ausin PP, Hidalgo A. Deep anterior lamellar keratoplasty in post-laser in situ keratomileusis keratectasia. J Cataract Refract Surg 2007 May;33(5):773-778.
  73. Grewal S, Laibson PR, Cohen EJ, Rapuano CJ. Acute hydrops in the corneal ectasias: Associated factors and outcomes. Trans Am Ophthalmol Soc 1999;97:187-98.
  74. Koenig SB, Smith RW. Keratoconus and corneal hydrops associated with compulsive eye rubbing. Refract Corneal Surg 1993;9:383-84.
  75. Mashor RS, Kumar NL, Ritenour RJ, Rootman DS. Keratoconus caused by eye rubbing in patients with Tourette syndrome. Can J Ophthalmol 2011;46:83-86.
  76. Kandarakis A, Karampelas M, Soumplis V, et al. A case of bilateral self-induced keratoconus in a patient with Tourette syndrome associated with compulsive eye rubbing: Case report. BMC Ophthalmol 2011;11:28.
  77. Coyle JT. Keratoconus and eye rubbing. Am J Ophthalmol 1984;97:527-28.
  78. Gritz DC, McDonnell PJ. Keratoconus and ocular massage. Am J Ophthalmol 1988;106:757-58.
  79. Rahi A, Davies P, Ruben M, et al. Keratoconus and coexisting atopic disease. Br J Ophthalmol 1977;61:761-64.
  80. Besancon G, Baikoff G, Deneux A, et al. Preliminary note on the psychological and mental status of patients with keratoconus. Bull Soc Ophtalmol Fr 1980;80:441-43.
  81. Copeman PW. Eczema and keratoconus. Br Med J 1965;2: 977-79.
  82. Mannis MJ, Morrison TL, Zadnik K, et al. Personality trends in keratoconus. An analysis. Arch Ophthalmol 1987;105:798-800.
  83. Swartz NG, Cohen EJ, Scott DG, et al. Personality and keratoconus. CLAO J 1990;16:62-64.
  84. Gasset AR, Hinson WA, Frias JL. Keratoconus and atopic diseases. Ann Ophthalmol 1978;10:991-94.
  85. Kaya V, Karakaya M, Utine CA, et al. Evaluation of the corneal topographic characteristics of keratoconus with orbscan II in patients with and without atopy. Cornea 2007;26:945-48.
  86. Galin MA, Berger R. Atopy and keratoconus. Am J Ophthalmol 1958;45:904-06.
  87. Roth HL, Keirland RR. The natural history of atopic dermatitis. A 20-year follow-up study. Arch Dermatol 1964;89:209-14.
  88. Lowell FC, Carroll JM. A study of the occurrence of atopic traits in patients with keratoconus. J Allergy 1970;46:32-39.
  89. Nemet AY, Vinker S, Bahar I, Kaiserman I. The association of keratoconus with immune disorders. Cornea 2010;29:1261-64.
  90. Buddi R, Lin B, Atilano SR, et al. Evidence of oxidative stress in human corneal diseases. J Histochem Cytochem 2002;50: 341-51.
  91. Kenney MC, Brown DJ. The cascade hypothesis of keratoconus. Cont Lens Anterior Eye 2003;26(3):139-46.
  92. Behndig A, Karlsson K, Johansson BO, et al. Superoxide dismutase isoenzymes in the normal and diseased human cornea. Invest Ophthalmol Vis Sci 2001;42:2293-96.
  93. Podskochy A, Fagerholm P. The expression of Fas ligand protein in ultraviolet-exposed rabbit corneas. Cornea 2002;21:91-94.
  94. Newkirk KM, Chandler HL, Parent AE, et al. Ultraviolet radiation-induced corneal degeneration in 129 mice. Toxicol Pathol 2007;35:819-26.
  95. Pettenati MJ, Sweatt AJ, Lantz P, et al. The human cornea has a high incidence of acquired chromosome abnormalities. Hum Genet 1997;101:26-29.
  96. Snibson GR. Collagen cross-linking: A new treatment paradigm in corneal disease—a review. Clin Experiment Ophthalmol 2010;38:141-53.
  97. Spoerl E, Raiskup-Wolf F, Kuhlisch E, Pillunat LE. Cigarette smoking is negatively associated with keratoconus. J Refract Surg 2008;24:S737-40.
  98. Rabinowitz YS, Nesburn AB, McDonnell PJ. Videokeratography of the fellow eye in unilateral keratoconus. Ophthalmology 1993;100:181-86.
  99. Goodrich DW, Lee WH. The molecular genetics of retinoblastoma. Cancer Surv 1990;9:529-54.
  100. Moodaley LC, Woodward EG, Liu CS, Buckley RJ. Life expectancy in keratoconus. Br J Ophthalmol 1992;76:590-91.
  101. Honein MA, Dawson AL, Petersen EE, Jones AM, Lee EH, Yazdy MM, Ahmad N, Macdonald J, Evert N, Bingham A, et al. Birth defects among fetuses and infants of US women with evidence of possible Zika virus infection during pregnancy. JAMA 2017 Jan 3;317(1):59-68.
  102. Chervenak FA, Jeanty P, Cantraine F, Chitkara U, Venus I, Berkowitz RL, Hobbins JC. The diagnosis of fetal microcephaly. Am J Obstet Gynecol 1984 Jul 1;149(5):512-517.
  103. Papageorghiou AT, Thilaganathan B, Bilardo CM, Ngu A, Malinger G, Herrera M, Salomon LJ, Riley LE, Copel JA. ISUOG Interim Guidance on ultrasound for Zika virus infection in pregnancy: information for healthcare professionals. Ultrasound Obstet Gynecol 2016 Apr;47(4):530-532.
  104. Chibueze EC, Parsons AJ, Lopes KD, Yo T, Swa T, Nagata C, Horita N, Morisaki N, Balogun OO, Dagvadorj A, et al. Diagnostic accuracy of ultrasound scanning for prenatal microcephaly in the context of Zika virus infection: a systematic review and meta-analysis. Sci Rep 2017 May 23;7(1):2310.
  105. Cordeiro MT. Zika virus: laboratory diagnosis. In: Zika in focus. Springer International Publishing; 2017. pp. 59-62.
  106. Mlakar J, Korva M, Tul N, Popović M, Poljšak-Prijatelj M, Mraz J, Kolenc M, Resman Rus K, Vesnaver Vipotnik T, Fabjan Vodušek V, et al. Zika virus associated with microcephaly. N Engl J Med 2016 Mar 10;374(10):951-958.
  107. Zare Mehrjardi M, Keshavarz E, Poretti A, Hazin AN. Neuroimaging findings of Zika virus infection: a review article. Jpn J Radiol 2016 Dec;34(12):765-770.
  108. Oliveira Melo AS, Malinger G, Ximenes R, Szejnfeld PO, Alves Sampaio S, Bispo de Filippis AM. Zika virus intrauterine infection causes fetal brain abnormality and microcephaly: tip of the iceberg? Ultrasound Obstet Gynecol 2016 Jan;47(1):6-7.
  109. Araujo AQ, Silva MT, Araujo AP. Zika virus-associated neurological disorders: a review. Brain 2016;139(8):2122-2130.
  110. Brasil P, Pereira JP Jr, Moreira ME, Ribeiro Nogueira RM, Damasceno L, Wakimoto M, Rabello RS, Valderramos SG, Halai UA, Salles TS, et al. Zika virus infection in pregnant women in Rio de Janeiro. N Engl J Med 2016 Dec 15;375(24):2321-2334.
PDF Share

© Jaypee Brothers Medical Publishers (P) LTD.